Mani (MNICF) Other Stockholders Equity: $45.0 Mil (As of Feb. 2026)


MNICF Mani Inc MNICF
98 GF Score
Price $12.82
GF Value $15.90
! 6 Warning Signs
View Full Analysis

What is Mani Other Stockholders Equity?

Mani MNICF 98 Other Stockholders Equity is $45.0 Mil as of Feb. 2026. GuruFocus rates MNICF with a GF Score™ of 98/100 and a GF Value™ of $15.90. The stock has 6 warning signs investors should review.

Mani's Other Stockholders Equity for the quarter that ended in Feb. 2026 was $45.0 Mil.

Mani's quarterly Other Stockholders Equity increased from Aug. 2025 ($37.3 Mil) to Nov. 2025 ($45.1 Mil) but then declined from Nov. 2025 ($45.1 Mil) to Feb. 2026 ($45.0 Mil).

Mani's annual Other Stockholders Equity declined from Aug. 2023 ($36.5 Mil) to Aug. 2024 ($34.9 Mil) but then increased from Aug. 2024 ($34.9 Mil) to Aug. 2025 ($37.3 Mil).

Mani Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Mani's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mani Other Stockholders Equity Chart

Mani Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.02 28.36 36.54 34.94 37.34

Mani Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.19 34.53 37.34 45.15 44.97
MNICF
98GF Score
Mani Inc MNICF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mani Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $45.0 Mil mean?
Mani (MNICF) has a Other Stockholders Equity of $45.0 Mil as of Feb. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Mani and its competitors.
Is Mani's Other Stockholders Equity too high?
Mani's current Other Stockholders Equity is $45.0 Mil. Overall, Mani has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Mani's Other Stockholders Equity compare to ISRG and BDX?
Mani's Other Stockholders Equity of $45.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Mani and its competitors. Mani's current Other Stockholders Equity is $45.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Mani (MNICF) has a current Other Stockholders Equity of $45.0 Mil. The stock's GF Value™ is $15.90, compared to a current price of $12.82 — trading 19.4% below its estimated fair value. The current Other Stockholders Equity is $45.0 Mil. Mani's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Mani (MNICF), the current Other Stockholders Equity is $45.0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mani (MNICF) Overvalued in 2026?

Based on GuruFocus' analysis, Mani stock appears to be undervalued. The current stock price of $12.82 is trading 19.4% below its estimated GF Value™ of $15.90.

Key valuation signals for MNICF:

  • Other Stockholders Equity: $45.0 Mil
  • GF Value™: $15.90 vs. price of $12.82 (19.4% below fair value)
  • GF Score™: 98/100 with 6 warning signs

No single metric tells the full story. See the MNICF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mani Business Description

Other Exchanges 7730:Japan
Address 8-3 Kogyodanchi, Tochigi, JPN
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
98GF Score

Get the complete analysis for MNICF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.82
Price
$15.90
GF Value